Rurik “Rik” G. Vandevenne
Rik joined River Cities in 2004 to focus on information technology and healthcare investment opportunities. He brings to River Cities a strong background in strategy and business management at high-growth companies. Rik is responsible for sourcing and evaluating new investment opportunities and working with executives in portfolio companies on marketing, sales execution, product development and strategy.
Prior to his private equity career, Rik gained experience working with venture backed companies in the strategy group of Scient, a global eBusiness consulting firm. Before Scient, Rik worked for four years at Accenture, first in the healthcare services group and then at the Internet Center of Excellence where he helped launch several venture-backed companies as well as worked on the team that developed the online music platform for BestBuy.
Rik serves on the boards of Netsertive, Advanced Practice Strategies, Continuity Control, ABT Molecular Imaging, EndoChoice, Univa and as an observer on the board of Veran Medical Technologies. He was previously on the board of APS, which sold to Relias Learning in 2016; EndoChoice would had an IPO in 2015 and sold to Boston Scientific (NYSE: BSX) in 2016; an observer on the board of Pioneer Surgical, which sold to RTI Surgical (Nasdaq: RTIX) in 2013; and on the board of Fullscope (sold to Edgewater (Nasdaq: EDGW) in 2009).
Rik graduated from Vanderbilt University where he received his BE in Mechanical Engineering, and he received an MBA from Duke University.
E-mail: rgv [@] rccf.com